DE2518842C3 - lalpha-Hydroxy- und 1,25-Dihydroxyergocalciferol und Verfahren zu ihrer Herstellung - Google Patents

lalpha-Hydroxy- und 1,25-Dihydroxyergocalciferol und Verfahren zu ihrer Herstellung

Info

Publication number
DE2518842C3
DE2518842C3 DE19752518842 DE2518842A DE2518842C3 DE 2518842 C3 DE2518842 C3 DE 2518842C3 DE 19752518842 DE19752518842 DE 19752518842 DE 2518842 A DE2518842 A DE 2518842A DE 2518842 C3 DE2518842 C3 DE 2518842C3
Authority
DE
Germany
Prior art keywords
hydroxyergocalciferol
production
hydroxy
diacetoxyvitamin
diacetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19752518842
Other languages
German (de)
English (en)
Other versions
DE2518842A1 (de
DE2518842B2 (de
Inventor
Hector Floyd Prof. Madison Deluca
Glenville Madison Jones
Hing-Yat Winnipeg Manitoba Lam (Kanada)
Heinrich Konstantin Waunakee Schnoes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US472953A external-priority patent/US3880894A/en
Priority claimed from US479224A external-priority patent/US3907843A/en
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of DE2518842A1 publication Critical patent/DE2518842A1/de
Publication of DE2518842B2 publication Critical patent/DE2518842B2/de
Application granted granted Critical
Publication of DE2518842C3 publication Critical patent/DE2518842C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19752518842 1974-05-24 1975-04-28 lalpha-Hydroxy- und 1,25-Dihydroxyergocalciferol und Verfahren zu ihrer Herstellung Expired DE2518842C3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US472953A US3880894A (en) 1974-05-24 1974-05-24 1,25-Dihydroxyergocalciferol
US479224A US3907843A (en) 1974-06-14 1974-06-14 1{60 -Hydroxyergocalciferol and processes for preparing same

Publications (3)

Publication Number Publication Date
DE2518842A1 DE2518842A1 (de) 1975-12-04
DE2518842B2 DE2518842B2 (de) 1978-03-02
DE2518842C3 true DE2518842C3 (de) 1978-11-02

Family

ID=27043973

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752518842 Expired DE2518842C3 (de) 1974-05-24 1975-04-28 lalpha-Hydroxy- und 1,25-Dihydroxyergocalciferol und Verfahren zu ihrer Herstellung

Country Status (3)

Country Link
DE (1) DE2518842C3 (nl)
FR (2) FR2271835B1 (nl)
GB (1) GB1503942A (nl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822479B2 (ja) * 1977-09-07 1983-05-09 帝人株式会社 １α−ヒドロキシ−２４−オキソ−ビタミンＤ↓３およびその製造法

Also Published As

Publication number Publication date
FR2271835B1 (nl) 1980-01-25
FR2271835A1 (nl) 1975-12-19
FR2366275A1 (fr) 1978-04-28
DE2518842A1 (de) 1975-12-04
FR2366275B1 (nl) 1980-04-11
GB1503942A (en) 1978-03-15
DE2518842B2 (de) 1978-03-02

Similar Documents

Publication Publication Date Title
DE2259661C3 (de) 1 alpha-Hydroxycholecalciferol Verfahren zu dessen Herstellung und dieses enthaltendes Geflügel- oder Tierfutter
DE2526981C3 (de) lalpha^4-Dihyaroxycholecalciferol-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Mittel
DE3248900C2 (nl)
DE2400931A1 (de) Derivate des vitamin d und verfahren zu ihrer herstellung
DE3590232C2 (de) 1,24-Dihydroxy- 22-Vitamin D3-Derivate, diese enthaltende Arzneimittel sowie Cholesterinderivate alsZwischenprodukte
CH651295A5 (de) 25-hydroxy-26,26,26,27,27,27-hexafluorcholecalciferol.
CH650240A5 (de) 24,24-difluor-1alpha,25-dihydroxycholecalciferol.
CH647760A5 (de) Verfahren zur herstellung von 1-hydroxycalciferolen und deren derivaten.
CH620453A5 (nl)
DE2518842C3 (de) lalpha-Hydroxy- und 1,25-Dihydroxyergocalciferol und Verfahren zu ihrer Herstellung
DE3243073A1 (de) 23-dehydro-25-hydroxyvitamin d(pfeil abwaerts)3(pfeil abwaerts)
DE2426779A1 (de) 1.3-oxygenierte 8 alpha-oestratriene
DE1568308B2 (de) Verfahren zur herstellung von delta hoch 4,9,11-trienen der 19-nor- androstanreihe, 17-oxygenierte 3-oxo- 7 alpha-methyl-delta hoch 4,9,11-19 nor- androstatriene und diese enthaltende pharmazeutische praeparate sowie 3-oxo-7 alpha -methyl-delta hoch 5 (10), 9 (11) -19-nor- androstadiene
DE2517293C2 (de) Neue Cardenolid-β-Glykoside, ihre Herstellung und Verwendung
Green et al. The isolation and structure of 23-deoxyantheridiol and the synthesis of its C-22 epimer
DE3490749C2 (de) 11-Desoxy-17alpha-hydroxycorticosteronester
DE3590080C2 (nl)
DE3045288C2 (nl)
DE3243150A1 (de) Trihydroxy-vitamin-d(pfeil abwaerts)3(pfeil abwaerts)-verbindungen
DE2945124A1 (de) Verfahren zur herstellung von 1 alpha, 3 beta -dihydroxy- delta hoch 5 -steroiden
DE2812741A1 (de) Vitamin d tief 3 -derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2518843C3 (de) Verfahren zu seiner Herstellung
DE1568308C3 (de) 10.09.65 Schweiz 12624-65 Verfahren zur Herstellung von Delta hoch 4,9,11-Trienen der 19-Norandrostanreihe, 17-oxygenierte 3-Oxo-7 alpha-methyl-Delta hoch 4,9,11-19 norandrostatriene und diese enthaltende pharmazeutische Präparate sowie 3-Oxo-7 alpha -methyl-Delta hoch 5 (10), 9 (11) -19-norandrostadiene
DE1493229B1 (de) Verfahren zur Gewinnung von Cholecalciferol
DE2953443C2 (de) 1ALPHA, 3beta-DIHYDROXY-9,10-seco-24-Norchola-5,7,10,(19)-trien-23-SAEURE UND ESTER DAVON.

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)